{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T06:24:41Z","timestamp":1792304681357,"version":"4.4.0"},"reference-count":104,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,2]],"date-time":"2015-07-02T00:00:00Z","timestamp":1435795200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["dldjournalonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.dld.2015.06.010","type":"journal-article","created":{"date-parts":[[2015,7,6]],"date-time":"2015-07-06T03:20:47Z","timestamp":1436152847000},"page":"903-912","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"title":["Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015"],"prefix":"10.1016","volume":"47","author":[{"given":"Rocco Maurizio","family":"Zagari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Ojetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhold","family":"Stockbrugger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Gullini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Annibale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Farinati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzo","family":"Ierardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Maconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Rugge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Di Mario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Luzza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Pretolani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2872-7167","authenticated-orcid":false,"given":"Antonella","family":"Savio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Gasbarrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Caselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2015.06.010_bib0525","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","article-title":"Management of Helicobacter pylori infection \u2013 the Maastricht IV\/Florence Consensus Report","volume":"61","author":"Malfertheiner","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.dld.2015.06.010_bib0530","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-2000-14876","article-title":"Are guidelines followed in Helicobacter pylori diagnosis and therapy? An inquiry among gastroenterologists, referring physicians and patients in Munich","volume":"38","author":"Fritz","year":"2000","journal-title":"Zeitschrift fur Gastroenterologie"},{"key":"10.1016\/j.dld.2015.06.010_bib0535","doi-asserted-by":"crossref","first-page":"7580","DOI":"10.1016\/S1590-8658(01)80139-0","article-title":"Cervia working group report: guidelines on the diagnosis and treatment of Helicobacter pylori infection","volume":"33","author":"Caselli","year":"2001","journal-title":"Digestive and Liver Disease"},{"key":"10.1016\/j.dld.2015.06.010_bib0540","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.dld.2007.05.016","article-title":"Cervia II working group report 2006: guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy","volume":"39","author":"Caselli","year":"2007","journal-title":"Digestive and Liver Disease"},{"key":"10.1016\/j.dld.2015.06.010_bib0545","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1038\/ctg.2013.3","article-title":"Helicobacter pylori test and treat strategy for management of dyspepsia: a comprehensive review","volume":"28","author":"Gisbert","year":"2013","journal-title":"Clinical and Translational Gastroenterology"},{"key":"10.1016\/j.dld.2015.06.010_bib0550","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1053\/j.gastro.2009.12.057","article-title":"Epidemiology of functional dyspepsia and subgroups in the Italian general population: an endoscopic study","volume":"138","author":"Zagari","year":"2010","journal-title":"Gastroenterology"},{"issue":"Suppl. 1","key":"10.1016\/j.dld.2015.06.010_bib0555","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hel.12165","article-title":"Epidemiology of Helicobacter pylori infection","volume":"19","author":"Eusebi","year":"2014","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2015.06.010_bib0560","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1177\/030089161309900318","article-title":"Estimated of cancer burden in Italy","volume":"99","author":"Rossi","year":"2013","journal-title":"Tumori"},{"key":"10.1016\/j.dld.2015.06.010_bib0565","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ejim.2014.08.010","article-title":"Prevalence of lesions detected at upper endoscopy: an Italian survey","volume":"25","author":"Zullo","year":"2014","journal-title":"European Journal of Internal Medicine"},{"key":"10.1016\/j.dld.2015.06.010_bib0570","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1136\/bmj.a1400","article-title":"Investigating dyspepsia","volume":"337a","author":"Zagari","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.dld.2015.06.010_bib0575","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1001\/archinternmed.2011.541","article-title":"Helicobacter pylori eradication for functional dyspepsia: what are we treating?: Comment on \u201cHelicobacter pylori eradication in functional dyspepsia\u201d","volume":"171","author":"Moayyedi","year":"2011","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.dld.2015.06.010_bib0580","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.bpg.2013.06.008","article-title":"Epidemiology of reflux symptoms and GORD","volume":"27","author":"Ronkainen","year":"2013","journal-title":"Best Practice & Research Clinical Gastroenterology"},{"key":"10.1016\/j.dld.2015.06.010_bib0585","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1523-5378.2011.00931.x","article-title":"The association between Barrett's esophagus and Helicobacter pylori infection: a meta-analysis","volume":"17","author":"Fischbach","year":"2012","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2015.06.010_bib0590","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.clon.2008.07.005","article-title":"Helicobacter pylori infection and oesophageal cancer risk: association studies via evidence-based meta-analyses","volume":"20","author":"Zhuo","year":"2008","journal-title":"Clinical Oncology"},{"key":"10.1016\/j.dld.2015.06.010_bib0595","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1136\/gutjnl-2012-302240","article-title":"The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention","volume":"62","author":"Lee","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.dld.2015.06.010_bib0600","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/ajg.2009.734","article-title":"Is there an increased risk of GERD after Helicobacter pylori eradication? A meta-analysis","volume":"105","author":"Yaghoobi","year":"2010","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.06.010_bib0605","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1523-5378.2011.00846.x","article-title":"Effect of HP eradication on gastroesophageal reflux disease","volume":"16","author":"Qian","year":"2011","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2015.06.010_bib0610","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1046\/j.1523-5378.2000.00032.x","article-title":"Changing patterns of Helicobacter pylori gastritis in long-standing acid suppression","volume":"5","author":"Moayyedi","year":"2000","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2015.06.010_bib0615","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/gut.2010.229286","article-title":"Long-term proton pump inhibitor administration, HP and gastric cancer: lessons from the gerbil","volume":"60","author":"Fox","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.dld.2015.06.010_bib0620","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1161\/CIR.0b013e318202f701","volume":"122","author":"Abraham","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.dld.2015.06.010_bib0625","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1161\/01.STR.0000028456.18614.93","article-title":"Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association)","volume":"33","author":"Coull","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.dld.2015.06.010_bib0630","first-page":"68","article-title":"Bleeding in patients using new anticoagulants or antiplatelet agents: risk factors and management","volume":"68","author":"Levi","year":"2010","journal-title":"Netherlands Journal of Medicine"},{"key":"10.1016\/j.dld.2015.06.010_bib0635","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1136\/gut.2010.228874","article-title":"Guidelines for the management of iron deficiency anaemia","volume":"60","author":"Goddard","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.dld.2015.06.010_bib0640","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0002-9343(01)00883-X","article-title":"Gastrointestinal causes of refractory iron deficiency anemia in patients without gastrointestinal symptoms","volume":"111","author":"Annibale","year":"2001","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.dld.2015.06.010_bib0645","first-page":"886","article-title":"Does Helicobacter pylori infection play a role in iron deficiency anemia? A meta-analysis","volume":"16","author":"Qu","year":"2010","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.06.010_bib0650","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/pgmj.2009.089987","article-title":"Iron deficiency anaemia can be improved after eradication of Helicobacter pylori","volume":"86","author":"Huang","year":"2010","journal-title":"Postgraduate Medical Journal"},{"key":"10.1016\/j.dld.2015.06.010_bib0655","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3109\/00365521003663670","article-title":"Iron deficiency anemia in Helicobacter pylori infection: meta-analysis of randomized controlled trials","volume":"45","author":"Yuan","year":"2010","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.06.010_bib0660","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/gut.52.4.496","article-title":"Concomitant alterations in intragastric pH and ascorbic acid concentration in patients with Helicobacter pylori gastritis and associated iron deficiency anaemia","volume":"52","author":"Annibale","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.dld.2015.06.010_bib0665","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/jac\/dkm195","article-title":"Effect of Helicobacter pylori eradication on platelet count in idiopathic thrombocytopenic purpura: a systematic review and meta-analysis","volume":"60","author":"Franchini","year":"2007","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.dld.2015.06.010_bib0670","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3324\/haematol.2008.005348","article-title":"Platelet count response to HP treatment in patients with immune thrombocytopenic purpura with and without HP infection: a systematic review","volume":"94","author":"Arnold","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.dld.2015.06.010_bib0675","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1182\/blood-2008-07-167155","article-title":"Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review","volume":"113","author":"Stasi","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.dld.2015.06.010_bib0680","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-5378.2011.00892.x","article-title":"(Other than iron) and Helicobacter pylori infection: a systematic review","volume":"17","author":"Lahner","year":"2012","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2015.06.010_bib0685","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.atherosclerosis.2008.04.051","article-title":"CagA antigen of Helicobacter pylori and coronary instability: insight from a clinico-pathological study and a meta-analysis of 4241 cases","volume":"202","author":"Franceschi","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.dld.2015.06.010_bib0690","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1007\/s00415-012-6558-7","article-title":"Helicobacter pylori infection contributes to high risk of ischemic stroke: evidence from a meta-analysis","volume":"259","author":"Wang","year":"2012","journal-title":"Journal of Neurology"},{"key":"10.1016\/j.dld.2015.06.010_bib0695","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/2050640614559262","article-title":"Helicobacter pylori infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea","volume":"3","author":"Gravina","year":"2015","journal-title":"United European Gastroenterology Journal"},{"key":"10.1016\/j.dld.2015.06.010_bib0700","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3748\/wjg.v21.i4.1305","article-title":"Accuracy of urea breath test in Helicobacter pylori infection: meta-analysis","volume":"2","author":"Ferwana","year":"2015","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.06.010_bib0705","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1111\/j.1572-0241.2006.00668.x","article-title":"Accuracy of monoclonal stool antigen test for the diagnosis of infection: a systematic review and meta-analysis","volume":"101","author":"Gisbert","year":"2006","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.06.010_bib0710","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1523-5378.2010.00757.x","article-title":"Accuracy of monoclonal stool tests for determining cure of Helicobacter pylori infection after treatment","volume":"15","author":"Calvet","year":"2010","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2015.06.010_bib0715","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2036.2004.02021.x","article-title":"Masking of 13C-urea breath test by proton pump inhibitors is dependent on type of medication: comparison between omeprazole, pantoprazole, lansoprazole and esomeprazole","volume":"20","author":"Levine","year":"2004","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.dld.2015.06.010_bib0720","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1080\/00365520410007944","article-title":"Accuracy of monoclonal antibody-based stool antigen test in the diagnosis of Helicobacter pylori infection","volume":"39","author":"Asfeldt","year":"2004","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.06.010_bib0725","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S1590-8658(01)80697-6","article-title":"Helicobacter pylori: diseases, tests and treatment","volume":"33","author":"Vaira","year":"2001","journal-title":"Digestive and Liver Disease"},{"key":"10.1016\/j.dld.2015.06.010_bib0730","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ajg.2011.2","article-title":"Has HP prevalence in bleeding peptic ulcer been underestimated? A meta-regression","author":"Sanchez-Delgado","year":"2011","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.06.010_bib0735","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1053\/gast.2001.27999","article-title":"Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection","volume":"121","author":"Ekstrom","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2015.06.010_bib0740","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/jac\/dkp445","article-title":"Phenotypic and genotypic Helicobacter pylori clarithromycin resistance and therapeutic outcome: benefits and limits","volume":"65","author":"De Francesco","year":"2010","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.dld.2015.06.010_bib0745","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1523-5378.2011.00912.x","article-title":"Fluoroquinolone resistance in Helicobacter pylori: role of mutations at position 87 and 91 of GyrA on the level of resistance and identification of a resistance conferring mutation in GyrB","volume":"17","author":"Rimbara","year":"2012","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2015.06.010_bib0750","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1128\/JCM.00744-09","article-title":"Evaluation of a new test, genotype HelicoDR, for molecular detection of antibiotic resistance in Helicobacter pylori","volume":"47","author":"Cambau","year":"2009","journal-title":"Journal of Clinical Microbiology"},{"key":"10.1016\/j.dld.2015.06.010_bib0755","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.3109\/00365521.2014.894117","article-title":"GenoType HelicoDR test in the determination of antimicrobial resistance of Helicobacter pylori in Korea","volume":"49","author":"Lee","year":"2014","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.06.010_bib0760","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1099\/jmm.0.067942-0","article-title":"Change of point mutations in the H. pylori rRNA associated with clarithromycin resistance in Italy","volume":"63","author":"De Francesco","year":"2014","journal-title":"Journal of Medical Microbiology"},{"key":"10.1016\/j.dld.2015.06.010_bib0765","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/MEG.0000000000000186","article-title":"Efficacy of real-time PCR-based detection of Helicobacter pylori infection and genotypic resistance-guided quadruple therapy as the first-line treatment for functional dyspepsia with Helicobacter pylori infection","volume":"27","author":"Liu","year":"2015","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2015.06.010_bib0770","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/jac\/39.5.585","article-title":"In-vitro activity of lansoprazole against Helicobacter pylori","volume":"39","author":"Figura","year":"1997","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.dld.2015.06.010_bib0775","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10620-005-2455-6","article-title":"Twice daily standard dose of omeprazole achieves the necessary level of acid inhibition for Helicobacter pylori eradication. A randomized controlled trial using standard and double doses of omeprazole in triple therapy","volume":"50","author":"Manes","year":"2005","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1016\/j.dld.2015.06.010_bib0780","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1365-2036.2008.03807.x","article-title":"Meta-analysis: high-dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication","volume":"28","author":"Villoria","year":"2008","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.dld.2015.06.010_bib0785","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00004836-200211000-00004","article-title":"The effect of Helicobacter pylori retreatment with ranitidine bismuth citrate, clarithromycin, and metronidazole depends on the first-line therapy","volume":"35","author":"Farup","year":"2002","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1016\/j.dld.2015.06.010_bib0790","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2036.1992.tb00564.x","article-title":"Short report: cefprozil for the eradication of Helicobacter pylori infection","volume":"6","author":"Malaty","year":"1992","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.dld.2015.06.010_bib0795","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/hel.12106","article-title":"Triple therapy with high-dose proton-pump inhibitor, amoxicillin, and doxycycline is useless for Helicobacter pylori eradication: a proof-of-concept study","volume":"19","author":"Almeida","year":"2014","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2015.06.010_bib0800","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gutjnl-2012-302254","article-title":"Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption","volume":"62","author":"Megraud","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.dld.2015.06.010_bib0805","article-title":"Optimum duration of regimens for Helicobacter pylori eradication","author":"Yang","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.dld.2015.06.010_bib0810","doi-asserted-by":"crossref","first-page":"553","DOI":"10.7326\/0003-4819-147-8-200710160-00008","article-title":"Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication","volume":"147","author":"Fuccio","year":"2007","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.dld.2015.06.010_bib0815","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1099\/jmm.0.072322-0","article-title":"Sequential, concomitant and hybrid first-line terapies for Helicobacter pylori eradication: a prospective randomized study","volume":"63","author":"Zullo","year":"2014","journal-title":"Journal of Medical Microbiology"},{"key":"10.1016\/j.dld.2015.06.010_bib0820","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1523-5378.2012.00945.x","article-title":"Helicobacter pylori infection: sequential therapy followed by levofloxacin-containing triple therapy provides a good cumulative eradication rate","volume":"17","author":"Manfredi","year":"2012","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2015.06.010_bib0825","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1136\/bmj.f4587","article-title":"Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy","volume":"347","author":"Gatta","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.dld.2015.06.010_bib0830","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/j.gastro.2013.03.050","article-title":"Optimized non-bismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with high rates of antibiotic resistance","volume":"145","author":"Molina-Infante","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2015.06.010_bib0835","first-page":"235","article-title":"Primary clarithromycin resistance in Helicobacter pylori: the multicentric Italian clarithromycin resistance observational (MICRO) Study","volume":"20","author":"De Francesco","year":"2011","journal-title":"Journal of Gastrointestinal and Liver Diseases"},{"key":"10.1016\/j.dld.2015.06.010_bib0840","first-page":"363","article-title":"High prevalence of primary antibiotic resistance in Helicobacter pylori isolates in Italy","volume":"21","author":"Saracino","year":"2012","journal-title":"Journal of Gastrointestinal and Liver Diseases"},{"key":"10.1016\/j.dld.2015.06.010_bib0845","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0140-6736(11)60020-2","volume":"377","author":"Malfertheiner","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2015.06.010_bib0850","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/gut.2009.198309","article-title":"Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with cross-over design","volume":"59","author":"Liou","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.dld.2015.06.010_bib0855","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3748\/wjg.v20.i3.665","article-title":"Eradication of Helicobacter pylori infection: which regimen first?","volume":"20","author":"Federico","year":"2014","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.06.010_bib0860","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.3748\/wjg.v18.i40.5669","article-title":"Levofloxacin\/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second line: a systematic review","volume":"18","author":"Di Caro","year":"2012","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.06.010_bib0865","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1136\/gut.2010.215350","article-title":"Empiric levofloxacin-containing vs clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomized trial","volume":"59","author":"Romano","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.dld.2015.06.010_bib0870","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1053\/j.gastro.2012.03.043","article-title":"Efficacy of 5-day levofloxacin-containing concomitant therapy in eradication of Helicobacter pylori infection","volume":"143","author":"Federico","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2015.06.010_bib0875","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1523-5378.2011.00844.x","article-title":"Second-line Helicobacter pylori eradication: a randomized comparison of 1 week or 2 week bismuth-containing quadruple therapy","volume":"16","author":"Chung","year":"2011","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2015.06.010_bib0880","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ajg.2008.87","article-title":"Cumulative HP eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen","volume":"104","author":"Rokkas","year":"2009","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.06.010_bib0885","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2036.2011.04937.x","article-title":"Review article: rifabutin in the treatment of refractory Helicobacter pylori infection","volume":"35","author":"Gisbert","year":"2012","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.dld.2015.06.010_bib0890","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.cgh.2012.12.007","article-title":"Culture-based selection therapy for patients who did not respond to previous treatment for Helicobacter pylori infection","volume":"11","author":"Fiorini","year":"2013","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2015.06.010_bib0895","doi-asserted-by":"crossref","first-page":"740381","DOI":"10.1155\/2012\/740381","article-title":"Impact of Lactobacillus reuteri supplementation on anti-Helicobacter pylori levofloxacin-based second-line therapy","volume":"2012","author":"Ojetti","year":"2012","journal-title":"Gastroenterology Research and Practice"},{"key":"10.1016\/j.dld.2015.06.010_bib0900","first-page":"384","article-title":"Use of probiotics in the fight against Helicobacter pylori","volume":"5","author":"Ruggero","year":"2014","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.06.010_bib0905","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/MCG.0b013e318266f6cf","article-title":"Meta-analysis of the efficacy and safety of Lactobacillus-containing and Bifidobacterium-containing probiotic compound preparation in Helicobacter pylori eradication therapy","volume":"47","author":"Wang","year":"2013","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1016\/j.dld.2015.06.010_bib0910","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4321\/S1130-01082013000800002","article-title":"Lactobacillus-containing probiotic supplementation increases Helicobacter pylori eradication rate: evidence from a meta-analysis","volume":"105","author":"Zheng","year":"2013","journal-title":"Revista Espanola de Enfermedades Digestivas"},{"key":"10.1016\/j.dld.2015.06.010_bib0915","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1365-2036.2010.04457.x","article-title":"Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication ratesand side effects during treatment","volume":"32","author":"Szajewska","year":"2010","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"Suppl. 1","key":"10.1016\/j.dld.2015.06.010_bib0920","first-page":"S99","article-title":"The efficacy and safety of adding the probiotic Saccharomyces boulardii to standard triple therapy for eradication of HP: a randomized controlled trial","volume":"6","author":"Zojaji","year":"2013","journal-title":"Gastroenterology and Hepatology from Bed to Bench"},{"key":"10.1016\/j.dld.2015.06.010_bib0925","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1523-5378.2012.00944.x","article-title":"Helicobacter pylori infection in clinical practice: probiotics and a combination of probiotics + lactoferrin improve compliance, but not eradication, in sequential therapy","volume":"17","author":"Manfredi","year":"2012","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2015.06.010_bib0930","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1136\/bmj.g3174","article-title":"Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials","volume":"348","author":"Ford","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.dld.2015.06.010_bib0935","doi-asserted-by":"crossref","first-page":"121","DOI":"10.7326\/0003-4819-151-2-200907210-00009","article-title":"Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer?","volume":"151","author":"Fuccio","year":"2009","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.dld.2015.06.010_bib0940","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.mrgentox.2010.07.014","article-title":"When bacteria become mutagenic and carcinogenic: lessons from HP","volume":"703","author":"Touati","year":"2010","journal-title":"Mutation Research"},{"key":"10.1016\/j.dld.2015.06.010_bib0945","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1007\/s11033-014-3319-y","article-title":"Role of p16 gene promotor methylation in gastric carcinogenesis: a meta-analysis","volume":"41","author":"Wang","year":"2014","journal-title":"Molecular Biology Reports"},{"key":"10.1016\/j.dld.2015.06.010_bib0950","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nrgastro.2014.143","article-title":"Genetics of gastric cancer","volume":"11","author":"McLean","year":"2014","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"key":"10.1016\/j.dld.2015.06.010_bib0955","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00428-013-1458-5","article-title":"First-degree relatives of early-onset gastric cancer patients show a high risk for gastric cancer: phenotype and genotype profile","volume":"463","author":"Marcos-Pinto","year":"2013","journal-title":"Virchows Archiv"},{"key":"10.1016\/j.dld.2015.06.010_bib0960","doi-asserted-by":"crossref","first-page":"10486","DOI":"10.3748\/wjg.v20.i30.10486","article-title":"Clinical epidemiology of gastric cancer in Hehuang valley of China: a 10-year epidemiological study of gastric cancer","volume":"20","author":"Yan","year":"2014","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.06.010_bib0965","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/hel.12088","article-title":"JM. Epidemiology of Helicobacter pylori in Bhutan: the role of environment and geographic location","volume":"19","author":"Dorji","year":"2014","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2015.06.010_bib0970","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1523-5378.2011.00827.x","article-title":"Helicobacter pylori infection, intestinal metaplasia, and gastric cancer risk in Eastern Siberia","volume":"16","author":"Tsukanov","year":"2011","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2015.06.010_bib0975","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1046\/j.1365-2036.2002.01301.x","article-title":"Gastric mucosa atrophy: inter-observer consistency using new criteria for classification and grading","volume":"16","author":"Rugge","year":"2002","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.dld.2015.06.010_bib0980","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1055\/s-0031-1291491","volume":"44","author":"Dinis-Ribeiro","year":"2012","journal-title":"Endoscopy"},{"key":"10.1016\/j.dld.2015.06.010_bib0985","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1365-2036.2001.00888.x","article-title":"Non-Helicobacter pylori bacterial flora during acid-suppressive therapy: differential findings in gastric juice and gastric mucosa","volume":"15","author":"Sanduleanu","year":"2001","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.dld.2015.06.010_bib0990","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1523-5378.2009.00665.x","article-title":"High-risk population for gastric cancer development based on serum pepsinogen status and lifestyle factors","volume":"14","author":"Yamaji","year":"2009","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2015.06.010_bib0995","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1258\/0969141041732184","article-title":"Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening","volume":"11","author":"Dinis-Ribeiro","year":"2004","journal-title":"Journal of Medical Screening"},{"key":"10.1016\/j.dld.2015.06.010_bib1000","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/gut.2004.055400","article-title":"Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study","volume":"54","author":"Watabe","year":"2005","journal-title":"Gut"},{"issue":"Suppl. 2","key":"10.1016\/j.dld.2015.06.010_bib1005","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1016\/S1590-8658(14)60265-6","article-title":"Sensitivity and specificity of the panel test \u201cGastropanel\u201d for the non invasive diagnosis of atrophic gastritis","volume":"46","author":"Rabitti","year":"2014","journal-title":"Digestive and Liver Disease"},{"key":"10.1016\/j.dld.2015.06.010_bib1010","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.ejso.2006.09.006","article-title":"Gastric stump carcinoma \u2013 epidemiology and current concepts in pathogenesis and treatment","volume":"33","author":"Sinning","year":"2007","journal-title":"European Journal of Surgical Oncology"},{"key":"10.1016\/j.dld.2015.06.010_bib1015","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1097\/MEG.0b013e3283398d37","article-title":"Helicobacter pylori infection and gastric histology in first degree relatives of gastric cancer patients: a meta-analysis","volume":"22","author":"Rokkas","year":"2010","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2015.06.010_bib1020","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/sj.bjc.6605024","article-title":"Proton pump inhibitors and risk of gastric cancer: a population based cohort-study","volume":"100","author":"Poulsen","year":"2009","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.dld.2015.06.010_bib1025","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/ijc.22157","article-title":"Smoking and alcohol drinking in relation to risk of gastric cancer: a population based, prospective cohort study","volume":"120","author":"Sjodahl","year":"2007","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.dld.2015.06.010_bib1030","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/oemed-2011-100071","article-title":"Occupational exposures and risk of stomach cancer by histological type","volume":"69","author":"Santibanez","year":"2012","journal-title":"Occupational and Environmental Medicine"},{"key":"10.1016\/j.dld.2015.06.010_bib1035","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.3748\/wjg.v17.i41.4596","article-title":"Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment","volume":"17","author":"Rugge","year":"2011","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.06.010_bib1040","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/j.1365-2036.2010.04277.x","article-title":"Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinic-pathological follow-up study","volume":"31","author":"Rugge","year":"2010","journal-title":"Alimentary Pharmacology and Therapeutics"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865815003783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865815003783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T21:30:58Z","timestamp":1748467858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865815003783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":104,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S1590865815003783"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2015.06.010","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2015.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}